To analyze the biological consequences of the miR-200c-driven repression of KRAS in breast cancer cells, we investigated whether increasing or decreasing the expression of miR-200c would have an impact on cell proliferation and clone formation in MBA-MD-231 and 4T1 cells. This evidence concerns the gene KRAS and breast carcinoma.